Pharmalot By Ed Silverman Judge bars Shkreli from running another public company, fines him $1.4 million
Politics By Rachel Cohrs Hospital, physician lobbies sue Biden administration over surprise billing regulation
Exclusive By Rachel Cohrs How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal
First Opinion By Ge Bai and David A. Hyman Tax exemptions for nonprofit hospitals: It’s time taxpayers get their money’s worth
Exclusive By Rachel Cohrs The Trump administration quietly spent billions in hospital funds on Operation Warp Speed
Health By Andrew Joseph ‘They don’t want his story to end’: Efforts to save the sperm of the deceased come with heartache and tough questions
Exclusive By Lev Facher Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence
First Opinion By Richard J. Baron and Ezekiel J. Emanuel Politicians should not be deciding what constitutes good medicine
Politics By Lev Facher Following Lander’s resignation, here’s who might be in line for White House science adviser
Politics By Nicholas Florko Moderate Democrats are still seeking changes to the party’s drug pricing package
First Opinion By Stephen Asiimwe, Edith Nakku-Joloba and Aggrey Semeere Isolated in Uganda: How Covid-19 evacuations highlight unfairness of global health partnerships
First Opinion By Natalie Ma My company is developing new antibiotics. My resistant infection showed me we need them now
Exclusive By Rachel Cohrs and Nicholas Florko Key Senate committee considers a carveout for small biotech companies in drug pricing reforms
Politics By Rachel Cohrs Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?
Politics By Rachel Cohrs and Lev Facher In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices
Politics By Rachel Cohrs Vulnerable Senate Democrats escalate a push for Medicare to negotiate drug prices
Health By Lev Facher For the first time ever, Lander’s White House science office will have an entire wing dedicated to health
Politics By Rachel Cohrs Senate Democrats eye drug pricing policies to fund $3.5 trillion budget deal
Politics By Rachel Cohrs Washington’s antitrust push could limit Amazon, Google’s health care ambitions
Biotech By Damian Garde and Nicholas Florko Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug
First Opinion By Sevahn Vorperian and Stephen Quake The PASTEUR Act can help win the war against superbugs
Politics By Nicholas Florko Powerful Democrat’s new drug pricing manifesto hints at a carveout for small biotechs